> "survival" is the wrong word; its terminal.
No one actually knows that one way or the other since some patients were still taking it after the study ended according to the article.
> "survival" is the wrong word; its terminal.
No one actually knows that one way or the other since some patients were still taking it after the study ended according to the article.
According to the abstract of the article, there were 2 groups of patients.
One group had median values of 8.5 months for progression-free survival and 13.1 months for overall survival.
The other group had median values of 8.1 months for progression-free survival and 15.6 months for overall survival.
Overall Survival (OS) measures the time until death from any cause.
Progression-Free Survival (PFS) evaluates how long a treatment can delay disease progression or death.
So at least most of the patients from the study have died, because otherwise median values could not have been computed.
Thus the treatment had provided them a median life extension of about 3/4 years. The lucky ones probably have got more than an extra year.